{"classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"7"}]}],"title":"Day 1 - Pain"},{"categories":[{"measurements":[{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"3"}]}],"title":"Day 1 - Tenderness"},{"categories":[{"measurements":[{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"2"}]}],"title":"Day 1 - Erythema"},{"categories":[{"measurements":[{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"2"}]}],"title":"Day 1 - Induration and warmth at the injection site"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"1"}]}],"title":"Day 1 - Fever"},{"categories":[{"measurements":[{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"4"}]}],"title":"Day 1 - Chills"},{"categories":[{"measurements":[{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"2"}]}],"title":"Day 1 - Arthralgia/joint pain"},{"categories":[{"measurements":[{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"8"}]}],"title":"Day 1 - Malaise/fatigue"},{"categories":[{"measurements":[{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"5"}]}],"title":"Day 1 - Myalgia/body aches"},{"categories":[{"measurements":[{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"5"}]}],"title":"Day 1 - Headache"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"2"}]}],"title":"Day 1 - Nausea"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}]}],"title":"Day 1 - Vomiting"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}]}],"title":"Day 1 - Abdominal pain"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"2"}]}],"title":"Day 29 - Pain"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"1"}]}],"title":"Day 29 - Tenderness"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}]}],"title":"Day 29 - Erythema"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}]}],"title":"Day 29 - Induration and warmth at the injection site"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}]}],"title":"Day 29 - Fever"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}]}],"title":"Day 29 - Chills"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}]}],"title":"Day 29 - Arthralgia/joint pain"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}]}],"title":"Day 29 - Malaise/fatigue"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"1"}]}],"title":"Day 29 - Myalgia/body aches"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"1"}]}],"title":"Day 29 - Headache"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}]}],"title":"Day 29 - Nausea"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}]}],"title":"Day 29 - Vomiting"},{"categories":[{"measurements":[{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}]}],"title":"Day 29 - Abdominal pain"}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"10"},{"groupId":"OG006","value":"0"}],"units":"Participants"}],"description":"Reactogenicity of mRNA-1273 of a booster vaccination was assessed by physical examination findings following vaccination. A physical exam will be performed to assess general physical condition in the following areas: supraclavicular and axillary lymph nodes, cardiovascular, pulmonary, abdomen and skin and include an assessment of pain, tenderness, erythema, induration and warmth at the injection site, fever, chills, arthralgia/joint pain, malaise/fatigue, myalgia/body aches, headache, nausea, vomiting, and abdominal pain following vaccination.","groups":[{"description":"100 mcg (0.5 mL) messenger ribonucleic acid (mRNA)-1273 injection on day (D)1.","id":"OG000","title":"Chronic Lymphocytic Leukemia (CLL) Not on Active Therapy - Booster Phase"},{"description":"100 mcg (0.5 mL) messenger ribonucleic acid (mRNA)-1273 injection on day (D)1.","id":"OG001","title":"Chronic Lymphocytic Leukemia(CLL) Receiving Bruton´s Tyrosine Kinase(BTK) Interruption-Booster Phase"},{"description":"100 mcg (0.5 mL) messenger ribonucleic acid (mRNA)-1273 injection on day (D)1.","id":"OG002","title":"Chimeric Antigen Receptor (CAR) T Cell Therapy - Booster Phase"},{"description":"100 mcg (0.5 mL) messenger ribonucleic acid (mRNA)-1273 injection on day (D)1.","id":"OG003","title":"Solid Tumor on Programmed Cell Death protein1/Programmed Cell Death Ligand 1 Inhibitor-Booster Phase"},{"description":"100 mcg (0.5 mL) messenger ribonucleic acid (mRNA)-1273 injection on day (D)1.","id":"OG004","title":"Post Allogeneic Transplant - Booster Phase"},{"description":"100 mcg (0.5 mL) messenger ribonucleic acid (mRNA)-1273 injection, intramuscular (IM) on day 1.","id":"OG005","title":"Other Hematologic Malignancy - Booster Phase"},{"description":"100 mcg (0.5 mL) messenger ribonucleic acid (mRNA)-1273 injection on day (D)1.","id":"OG006","title":"Other Adult Solid Tumor - Booster Phase"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"No participants were enrolled in Groups CLL, CLL/BTK, CAR-T Cell and Other Adult Solid Tumor Booster Phase. Regarding Other Hematologic Malignancy Booster Phase Group 1 participant crossed over from hematologic low immunosuppression-initial phase; 3 participants crossed over from hematologic intermediate immunosuppression-initial phase; 3 participants crossed over from hematologic high immunosuppression-initial phase; \\& 3 participants were initially enrolled (did not cross over) into this group.","reportingStatus":"POSTED","timeFrame":"End of 15-minute observation period following each vaccination on Day 1 and Day 29","title":"Number of Participants With Reactogenicity of Messenger Ribonucleic Acid (mRNA) -1273 of a Booster Vaccination: Booster Phase","type":"PRIMARY","unitOfMeasure":"Participants"}